Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Ensign Group expands with new healthcare acquisitions

EditorNatashya Angelica
Published 01/05/2024, 20:00
ENSG
-

SAN JUAN CAPISTRANO, Calif. - The Ensign Group , Inc. (NASDAQ:ENSG), a diversified provider of healthcare services, announced today the acquisition of two healthcare facilities in Bountiful, Utah, marking the company's first foray into the long-term acute care hospital market.

The acquired facilities include South Davis Specialty Care, a 95-bed skilled nursing operation, and Western Peaks Specialty Hospital, a 43-bed long-term acute care hospital. The real estate for these facilities was purchased by a subsidiary of Standard Bearer Healthcare REIT, Inc., Ensign's captive real estate company.

Barry Port, CEO of Ensign, expressed the company's commitment to a smooth transition into this new line of business, highlighting the leadership team's readiness for the challenge. Steve Farnsworth, President of Milestone Healthcare LLC, Ensign's Utah-based subsidiary, also conveyed optimism about the integration of the new team with Ensign's existing operations in Utah.

Moreover, Ensign acquired six other operations on the same day, three of which included real estate assets also acquired by Standard Bearer. These operations span across multiple states, including Arizona, Iowa, Kansas, Tennessee, and Texas.

The acquisitions include a mix of skilled nursing facilities, assisted living units, and independent living units, further expanding Ensign's portfolio to 310 healthcare operations, 29 of which also offer senior living services.

Ensign's subsidiaries now own 119 real estate assets, and the company continues to actively seek opportunities to acquire and lease healthcare-related businesses across the United States. The acquisitions, effective as of today, represent Ensign's strategic growth in the healthcare sector and its dedication to providing a range of services to meet the diverse needs of its patients.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This expansion underscores Ensign's position as a major player in the healthcare industry, with a footprint that extends across fourteen states. The information provided is based on a press release statement from The Ensign Group, Inc.

InvestingPro Insights

The Ensign Group's strategic acquisitions in the healthcare sector are complemented by its strong financial metrics and market performance. According to InvestingPro data, Ensign Group (NASDAQ:ENSG) has a market capitalization of $6.74 billion and has experienced a notable revenue growth of 23.27% over the last twelve months as of Q4 2023.

This growth is reflective of the company's aggressive expansion strategy and its ability to integrate new operations effectively.

InvestingPro Tips highlight that Ensign Group has demonstrated a commitment to shareholder returns, raising its dividend for 17 consecutive years, with a dividend growth of 4.35% in the last twelve months.

This consistent increase in dividends signals the company's financial health and its confidence in maintaining a steady cash flow. Furthermore, analysts have revised their earnings upwards for the upcoming period, indicating a positive outlook on the company's profitability.

While Ensign trades at a high earnings multiple with a P/E ratio of 31.45, indicating a premium valuation, the company's stock is known for low price volatility. This could be an attractive attribute for investors seeking stable growth in the healthcare sector.

For those interested in a deeper dive into Ensign's financials and future projections, InvestingPro offers additional insights and metrics. There are 12 more InvestingPro Tips available for Ensign Group, which can be accessed by visiting InvestingPro. Use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, enriching your investment strategy with valuable, real-time data and analysis.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.